Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LivaNova PLC Director's Dealing 2025

Dec 17, 2025

31419_dirs_2025-12-17_ce883792-f63e-4f67-a259-a6c1a69dae71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LivaNova PLC (LIVN)
CIK: 0001639691
Period of Report: 2025-12-15

Reporting Person: Poletti Franco (President, Cardiopulmonary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-15 Ordinary Shares M 967 Acquired 9266 Direct
2025-12-15 Ordinary Shares F 416 $63.06 Disposed 8850 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-15 Restricted Stock Units $ M 967 Disposed Ordinary Shares (967) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 219 Indirect

Footnotes

F1: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

F2: Shares withheld to satisfy tax liability.

F3: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture
prior to vesting in accordance with the terms of the Plan and the award agreement.